| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.09B | -15.5% |
| Cost of Revenue | $2.59B | -15.4% |
| Gross Profit | $1.49B | -15.7% |
| R&D Expense | $121.7M | -35.1% |
| SG&A Expense | $478.5M | -4.9% |
| Operating Income | $265.2M | +29.5% |
| Income Tax | -$38.3M | -253.8% |
| Net Income | -$162.6M | -211.3% |
| EPS (Basic) | -$1.20 |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $600.7M | +69.5% |
| Accounts Receivable | $697.1M | -43.9% |
| Inventory | $1.15B | +18.9% |
| Current Assets | $2.72B | -1.3% |
| Total Assets | $11.49B | +1.7% |
| Current Liabilities | $1.11B | -16.6% |
| Long-term Debt | $4.07B | +20.9% |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $636.2M | +64.1% |
| Capital Expenditures | $170.4M | +23.7% |
| Investing Cash Flow | -$187.8M | +68.5% |
| Financing Cash Flow | -$181.1M | — |
| Free Cash Flow | $465.8M | +86.2% |
| -212.1% |
| EPS (Diluted) | -$1.19 | -211.2% |
| Total Liabilities |
| $6.18B |
| +12.3% |
| Stockholders' Equity | $5.66B | -2.6% |